FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3025648038> ?p ?o ?g. }

• W3025648038 endingPage "100763" @default.
• W3025648038 startingPage "100763" @default.
• W3025648038 abstract "With programmed cell death 1 (PD-1) inhibitors approved for second-line treatment of advanced esophageal cancer, immunotherapy and chemotherapy have gradually become the main treatments for second-line treatment of patients with advanced esophageal cancer (AEC). This meta-analysis and systematic review were conducted to evaluate the efficacy and safety of PD-1 inhibitors monotherapy versus chemotherapy in second-line treatment of AEC.Eligible randomized controlled trials were searched in PubMed, Embase, and the Cochrane Library and abstracts presented at the American Society of Clinical Oncology or European Society of Medical Oncology were reviewed to assess the efficacy and tolerability of PD-1/programmed cell death ligand 1 (PD-L1) inhibitors relative to chemotherapy for AEC from January 2016 to October 2020. Patients diagnosed with AEC and progressing after first-line therapy were included in this study. Hazard ratios (HRs) of progression-free survival (PFS) and overall survival (OS), risk ratios (RRs) of objective response rate (ORR), and the odds ratios (ORs) of adverse effects (AEs) were calculated.The study included 4 randomized controlled trials with 1683 patients. The results indicated that PD-1 inhibitors prolonged the OS (HR = 0.79; 95% CI, 0.71–0.88; P < 0.01) and improved the ORR (RR = 3.00; 95% CI, 2.36–3.82; P = 0.01) but did not improve the PFS (HR = 0.96; 95% CI, 0.76–1.20; P = 0.692) compared with chemotherapy in the second-line treatment of AEC. PD-1 inhibitors alone were associated with a lower incidence of all treatment-related AEs (OR = 0.29; 95% CI, 0.09–0.89; P = 0.03) and grade 3 to 5 treatment-related AEs (OR = 0.26; 95% CI, 0.16–0.44; P < 0.01) versus chemotherapy. PD-1 inhibitors prolonged OS mainly in the following patient groups: male, age <65 years, Eastern Cooperative Oncology Group performance status of 1, or PD-L1 tumor proportion score ≥10%. Asian patients had a longer OS than non-Asian patients (P = 0.01).The available evidence indicates that the efficacy and tolerability of PD-1 inhibitors were better than chemotherapy in the second-line treatment of AEC, and the benefiting population of these patients was limited to males, those <65 years of age, those with a Eastern Cooperative Oncology Group performance status of 1, or those with a PD-L1 tumor proportion score ≥10%. Notably, Asian patients receiving immune monotherapy had longer OS than non-Asian patients." @default.
• W3025648038 created "2020-05-21" @default.
• W3025648038 creator A5048057602 @default.
• W3025648038 creator A5049677090 @default.
• W3025648038 date "2020-11-01" @default.
• W3025648038 modified "2023-10-12" @default.
• W3025648038 title "ERS guidelines on chronic cough: It is time to change the way we manage chronic cough" @default.
• W3025648038 cites W2006815126 @default.
• W3025648038 cites W2088140593 @default.
• W3025648038 cites W2088476769 @default.
• W3025648038 cites W2127376430 @default.
• W3025648038 cites W2160647821 @default.
• W3025648038 cites W2164090174 @default.
• W3025648038 cites W2524202081 @default.
• W3025648038 cites W2557217940 @default.
• W3025648038 cites W2969134416 @default.
• W3025648038 cites W2973217118 @default.
• W3025648038 doi "https://doi.org/10.1016/j.resmer.2020.100763" @default.
• W3025648038 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32498022" @default.
• W3025648038 hasPublicationYear "2020" @default.
• W3025648038 type Work @default.
• W3025648038 sameAs 3025648038 @default.
• W3025648038 citedByCount "0" @default.
• W3025648038 crossrefType "journal-article" @default.
• W3025648038 hasAuthorship W3025648038A5048057602 @default.
• W3025648038 hasAuthorship W3025648038A5049677090 @default.
• W3025648038 hasBestOaLocation W30256480381 @default.
• W3025648038 hasConcept C126322002 @default.
• W3025648038 hasConcept C143998085 @default.
• W3025648038 hasConcept C168563851 @default.
• W3025648038 hasConcept C197934379 @default.
• W3025648038 hasConcept C207103383 @default.
• W3025648038 hasConcept C2776478404 @default.
• W3025648038 hasConcept C2776694085 @default.
• W3025648038 hasConcept C2778375690 @default.
• W3025648038 hasConcept C44249647 @default.
• W3025648038 hasConcept C71924100 @default.
• W3025648038 hasConcept C95190672 @default.
• W3025648038 hasConceptScore W3025648038C126322002 @default.
• W3025648038 hasConceptScore W3025648038C143998085 @default.
• W3025648038 hasConceptScore W3025648038C168563851 @default.
• W3025648038 hasConceptScore W3025648038C197934379 @default.
• W3025648038 hasConceptScore W3025648038C207103383 @default.
• W3025648038 hasConceptScore W3025648038C2776478404 @default.
• W3025648038 hasConceptScore W3025648038C2776694085 @default.
• W3025648038 hasConceptScore W3025648038C2778375690 @default.
• W3025648038 hasConceptScore W3025648038C44249647 @default.
• W3025648038 hasConceptScore W3025648038C71924100 @default.
• W3025648038 hasConceptScore W3025648038C95190672 @default.
• W3025648038 hasLocation W30256480381 @default.
• W3025648038 hasLocation W30256480382 @default.
• W3025648038 hasLocation W30256480383 @default.
• W3025648038 hasLocation W30256480384 @default.
• W3025648038 hasOpenAccess W3025648038 @default.
• W3025648038 hasPrimaryLocation W30256480381 @default.
• W3025648038 hasRelatedWork W2087016115 @default.
• W3025648038 hasRelatedWork W2189666756 @default.
• W3025648038 hasRelatedWork W2305775430 @default.
• W3025648038 hasRelatedWork W2349164817 @default.
• W3025648038 hasRelatedWork W2465571689 @default.
• W3025648038 hasRelatedWork W2747457586 @default.
• W3025648038 hasRelatedWork W3184554080 @default.
• W3025648038 hasRelatedWork W3191427281 @default.
• W3025648038 hasRelatedWork W4292341104 @default.
• W3025648038 hasRelatedWork W4311628015 @default.
• W3025648038 hasVolume "78" @default.
• W3025648038 isParatext "false" @default.
• W3025648038 isRetracted "false" @default.
• W3025648038 magId "3025648038" @default.
• W3025648038 workType "article" @default.